Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ana Sofia Cruz Solbes, M.D.

Concepts (13)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Ana Cruz Solbes's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Ana Cruz Solbes has written about over time.
Animals, 1 publications between 2018 and 2018, average publication date May 2018. Epithelial Cells, 1 publications between 2018 and 2018, average publication date May 2018. Female, 1 publications between 2018 and 2018, average publication date May 2018. Humans, 1 publications between 2018 and 2018, average publication date May 2018. Influenza A Virus, H3N2 Subtype, 1 publications between 2018 and 2018, average publication date May 2018. Influenza, Human, 1 publications between 2018 and 2018, average publication date May 2018. Interferon Type I, 1 publications between 2018 and 2018, average publication date May 2018. Lung, 1 publications between 2018 and 2018, average publication date May 2018. Male, 1 publications between 2018 and 2018, average publication date May 2018. Mice, 1 publications between 2018 and 2018, average publication date May 2018. Mice, Inbred C57BL, 1 publications between 2018 and 2018, average publication date May 2018. Reactive Oxygen Species, 1 publications between 2018 and 2018, average publication date May 2018. Toll-Like Receptors, 1 publications between 2018 and 2018, average publication date May 2018.

To see the data from this visualization as text, click here.
Cruz Solbes's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (13)
Explore
_
Co-Authors (1)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.